Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease-Reference-Cited by-同舟云学术

Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease

Published:2013-03-11 Issue:5 Volume:161 Page:748-751
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Egan Jan B.¹,Kortuem K. Martin¹,Kurdoglu Ahmet²,Izatt Tyler²,Aldrich Jessica²,Reiman Rebecca²,Phillips Lori²,Baker Angela²,Shi Chang-Xin¹,Schmidt Jessica¹,Liang Winnie S.²,Craig David W.²,Carpten John D.²,Stewart A. Keith¹

Affiliation:

1. Mayo Clinic; Scottsdale; AZ; USA

2. Translational Genomics Research Institute; Phoenix; AZ; USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12291/fullpdf

Reference10 articles.

1. Targeting the PI3K signaling pathway in cancer therapy;Bartholomeusz;Expert Opinion on Therapeutic Targets,2012

2. Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms;Bray;Human Mutation,2003